## Diagnosis: Anterior Wall STEMI **Key Point:** This patient has acute anterior STEMI (ST elevation in V1–V4, reciprocal changes, elevated troponin) with a **door-to-PCI time of 180 minutes**, which exceeds the recommended 120-minute window. In this scenario, **fibrinolytic therapy is the preferred reperfusion strategy**. ## Reperfusion Strategy Selection ### Guideline-Based Decision Tree: ```mermaid flowchart TD A["STEMI confirmed<br/>ST elevation + troponin + symptoms"]:::outcome --> B{"PCI-capable hospital<br/>within 120 min?"}:::decision B -->|Yes| C["Primary PCI<br/>door-to-balloon <90 min"]:::action B -->|No| D{"Door-to-balloon<br/>would exceed 120 min?"}:::decision D -->|Yes| E["Fibrinolytic therapy<br/>within 30 min of diagnosis"]:::action D -->|No| F["Transfer for PCI<br/>if <120 min door-to-balloon"]:::action E --> G{"Reperfusion achieved?<br/>ECG improvement, pain relief"}:::decision G -->|No| H["Rescue PCI"]:::urgent G -->|Yes| I["Coronary angiography<br/>within 24 hours"]:::action ``` **High-Yield:** The 2017 ESC and 2015 ACC/AHA guidelines state: - **Primary PCI is preferred** if door-to-balloon time ≤120 minutes (ideally ≤90 min) - **Fibrinolytic therapy is preferred** if PCI cannot be performed within 120 minutes - **Fibrinolysis should be initiated within 30 minutes** of first medical contact ("door-to-needle" ≤30 min) ### This Patient's Scenario: - Door-to-PCI time = 180 minutes (exceeds 120-minute guideline threshold) - Door-to-needle (fibrinolysis) = <30 minutes (achievable) - **Therefore: Fibrinolytic therapy is the appropriate choice** ## Fibrinolytic Agent Selection | Agent | Fibrin-Specificity | Reperfusion Rate | Bleeding Risk | Dosing | |-------|-------------------|-----------------|---------------|--------| | **Alteplase (tPA)** | High | 70–80% | Moderate | 15 mg IV bolus, then 0.75 mg/kg over 30 min, then 0.5 mg/kg over 60 min | | Streptokinase | Low | 60–70% | Lower | 1.5 MU IV over 60 min | | Reteplase | High | 75–80% | Moderate | 10 U IV bolus × 2 (30 min apart) | | Tenecteplase | High | 80–85% | Moderate | Weight-based single bolus | **Clinical Pearl:** Alteplase is preferred in anterior STEMI due to superior reperfusion rates and lower reinfarction risk compared to streptokinase, despite slightly higher bleeding risk. ## Adjunctive Management: 1. **DAPT:** Aspirin 300 mg + clopidogrel 600 mg (or ticagrelor 180 mg) 2. **Anticoagulation:** UFH bolus 60 U/kg (max 4000 U) followed by infusion, OR enoxaparin 0.3 mg/kg IV 3. **Beta-blocker:** Metoprolol 25–50 mg (if no contraindications) 4. **Rescue PCI:** If ECG shows <50% ST-segment resolution at 60–90 minutes post-fibrinolysis, proceed to rescue PCI **Warning:** Do NOT delay fibrinolysis waiting for transfer or repeat ECG. Time is myocardium — every 30-minute delay increases 1-year mortality by ~7.5%. ## Why This Option is Correct Option 1 combines **immediate fibrinolytic therapy (alteplase) + DAPT**, which is guideline-concordant when PCI cannot be performed within 120 minutes. The plan for rescue PCI if reperfusion fails ensures safety and optimal outcomes. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.